Allarity Therapeutics
(NASDAQ) ALLR
Allarity Therapeutics Financials at a Glance
Market Cap
$17.21M
Revenue (TTM)
$0.00
Net Income (TTM)
$15.31M
EPS (TTM)
$-1.61
P/E Ratio
-0.67
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$1.07
Volume
150,248
Open
$1.07
Price
$1.07
Volume
150,248
Open
$1.07
Previous Close
$1.07
Daily Range
$1.04 - $1.10
52-Week Range
$0.61 - $2.35
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$1.07
Volume
150,248
Open
$1.07
Previous Close
$1.07
Daily Range
$1.04 - $1.10
52-Week Range
$0.61 - $2.35
ALLR News
ALLR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Allarity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Thomas H. Jensen
Website
www.allarity.comHeadquarters
Boston, MA 02139, US
ALLR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-123%
Return on Capital
-1%
Return on Assets
-74%
Earnings Yield
-1.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$17.21M
Shares Outstanding
16.08M
Volume
150.25K
Short Interest
0.00%
Avg. Volume
170.17K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$27.24M
EBITDA
$24.23M
Operating Cash Flow
$17.35M
Capital Expenditure
$298.00K
Free Cash Flow
$17.65M
Cash & ST Invst.
$19.53M
Total Debt
$1.35M
Allarity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$17.21M
N/A
Market Cap/Employee
$2.87M
N/A
Employees
6
N/A
Net Income
$2.81M
+75.8%
EBITDA
$2.75M
+76.9%
Quarterly Fundamentals
Net Cash
$15.51M
-9.5%
Accounts Receivable
$1.66M
+0.6%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.39M
+4.0%
Return on Assets
-73.62%
N/A
Return on Invested Capital
-1.42%
N/A
Free Cash Flow
$3.41M
+37.4%
Operating Cash Flow
$3.41M
+37.4%